Clinical pattern and progression of ulcerative proctitis in the Japanese population: A retrospective study of incidence and risk factors influencing progression

Colorectal Disease

Volumn 18, Issue 3, 2016, Pages O97-O102

  Anzai, H ^a   Hata, K ^a   Kishikawa, J ^a   Ishii, H ^a   Nishikawa, T ^a   Tanaka, T ^a   Tanaka, J ^a   Kiyomatsu, T ^a   Kawai, K ^a   Nozawa, H ^a   Kazama, S ^a   Yamaguchi, H ^a   Ishihara, S ^a   Sunami, E ^a   Kitayama, J ^a   Watanabe, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Dysplasia; Progression of ulcerative colitis; Younger age at symptom onset

Indexed keywords

ADULT; ARTICLE; CANCER RISK; DISEASE COURSE; DYSPLASIA; FEMALE; HUMAN; INCIDENCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCOLITIS; PRIORITY JOURNAL; PROCTITIS; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; ULCERATIVE PROCTITIS; AGE; COLORECTAL NEOPLASMS; COMPLICATION; FOLLOW UP; JAPAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCTOCOLITIS; RISK FACTOR;

ADULT; AGE FACTORS; AGE OF ONSET; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCTOCOLITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84962850095     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.13237     Document Type: Article

References (25)

1. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001; 7: 260-70.
2. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-46.
3. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
4. Ayres RC, Gillen CD, Walmsley RS, Allan RN. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996; 8: 555-8.
5. Russel MG. Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med 2000; 11: 191-6.
6. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
7. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
8. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
9. Lok KH, Hung HG, Ng CH et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol 2008; 23: 406-10.
10. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103: 3167-82.
11. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009; 44: 659-65.
12. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31: 329-33.
13. Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983; 85: 1-11.
14. Meucci G, Vecchi M, Astegiano M et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 469-73.
15. Kim B, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Proximal disease extension and related predicting factors in ulcerative proctitis. Scand J Gastroenterol 2014; 49: 177-83.
16. Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120: 13-20.
17. Hoie O, Wolters F, Riis L et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102: 1692-701.
18. Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking-a review. Am J Gastroenterol 1998; 93: 144-9.
19. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590-2.
20. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711-4.
21. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000; 14: 145-53.
22. Griffiths AM, Sherman PM. Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. J Pediatr Gastroenterol Nutr 1997; 24: 202-10.
23. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-23; quiz 24.
24. Annese V, Daperno M, Rutter MD et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018.
25. Hata K, Watanabe T, Kazama S et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer 2003; 89: 1232-6.